Morgan Stanley Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $45

Moomoo NewsNov 11 08:31 ET · Ratings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Waters (WAT), Pharvaris (PHVS) and Tandem Diabetes Care (TNDM)

TipRanksNov 11 08:21 ET · Ratings

Assessing MedTech Impact From Potential China Tariffs

Seeking AlphaNov 9 11:28 ET

Barclays Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $60

Moomoo NewsNov 9 03:33 ET · Ratings

A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $40 to $75

Moomoo NewsNov 8 08:00 ET · Ratings

Here's What Analysts Are Forecasting For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Results

Simply Wall StNov 8 05:03 ET